셀트리온제약

068760KOSDAQView the 제약 sectorTheme Bio & healthcare

39,350KRWMarket close of 10/21 (Wed)

Down -0.13%-50KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)38,600KRWDown -1.91%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
40,250
High
40,850
Low
39,100
Day range
Day range low 39,100 high 40,850, open 40,250, close 39,350, previous close 39,400
Volume
5×10K shares
2.0B KRW 0.60× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 36,550 to 75,700 won, 7% up from the low

7% of the way up from the lowest close in 1 year (252 sessions) · -48.0% from the high

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Daily moveusual range-0.13%-0.13%, 0.1× the usual (20-session average ±1.99%)
    That day -0.13% · usual ±1.99% · large-move threshold ±4.0%
  • Trading valueusual range0.6×2.0B KRW, 0.6× the 20-session average
    0.60× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+4.3B KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.